A catemer-to-dimer structural transformation in cyheptamide

被引：25

作者：

Florence, A. J. ^{[1
]}

Shankland, K. ^{[2
]}

Gelbrich, T. ^{[3
]}

Hursthouse, M. B. ^{[3
]}

Shankland, N. ^{[1
]}

Johnston, A. ^{[1
]}

Fernandes, P. ^{[1
]}

Leech, C. K. ^{[2
]}

机构：

[1] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Solidstate Res Grp, Glasgow G4 0NR, Lanark, Scotland

[2] Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England

[3] Univ Southampton Highfield, Sch Chem, Southampton SO17 1BJ, Hants, England

来源：

CRYSTENGCOMM | 2008年 / 10卷 / 01期

基金：

英国工程与自然科学研究理事会;

关键词：

D O I：

10.1039/b712547j

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A catemeric crystal structure of cyheptamide undergoes a transformation in the solid-state upon heating to produce a dimer-based form whose structure has been determined from laboratory X-ray powder diffraction ( XRPD) data, thereby providing the first conclusive evidence of a carbamazepine analogue crystallising in both hydrogen bonded motifs.

引用

页码：26 / 28

页数：3

共 21 条

[1] X-RAY CRYSTALLOGRAPHIC CHARACTERIZATION OF 10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE [J].

BANDOLI, G ;

NICOLINI, M ;

ONGARO, A ;

VOLPE, G ;

RUBELLO, A .

JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH, 1992, 22 (02) :177-183

[2]

COELHO AA, 2003, TOPAS USER MANUAL V

[3] Importance of molecular shape for the overall stability of hydrogen bond motifs in the crystal structures of various carbamazepine-type drug molecules [J].

Cruz Cabeza, Aurora J. ;

Day, Graeme M. ;

Motherwell, W. D. Samuel ;

Jones, William .

CRYSTAL GROWTH & DESIGN, 2007, 7 (01) :100-107

[4] Routine determination of molecular crystal structures from powder diffraction data [J].

David, WIF ;

Shankland, K ;

Shankland, N .

CHEMICAL COMMUNICATIONS, 1998, (08) :931-932

[5] DASH:: a program for crystal structure determination from powder diffraction data [J].

David, William I. F. ;

Shankland, Kenneth ;

van de Streek, Jacco ;

Pidcock, Elna ;

Motherwell, W. D. Samuel ;

Cole, Jason C. .

JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2006, 39 :910-915

[6] Solving molecular crystal structures from X-ray powder diffraction data:: The challenges posed by γ-carbamazepine and chlorothiazide N,N,-dimethylformamide (1/2) solvate [J].

Fernandes, Philippe ;

Shankland, Kenneth ;

Florence, Alastair J. ;

Shankland, Norman ;

Johnston, Andrea .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (05) :1192-1202

[7] Crystal engineering of the composition of pharmaceutical phases:: Multiple-component crystalline solids involving carbamazepine [J].

Fleischman, SG ;

Kuduva, SS ;

McMahon, JA ;

Moulton, B ;

Walsh, RDB ;

Rodríguez-Hornedo, N ;

Zaworotko, MJ .

CRYSTAL GROWTH & DESIGN, 2003, 3 (06) :909-919

[8] Control and prediction of packing motifs: a rare occurrence of carbamazepine in a catemeric configuration [J].

Florence, A. J. ;

Leech, C. K. ;

Shankland, N. ;

Shankland, K. ;

Johnston, A. .

CRYSTENGCOMM, 2006, 8 (10) :746-747

[9] An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine [J].

Florence, Alastair J. ;

Johnston, Andrea ;

Price, Sarah L. ;

Nowell, Harriott ;

Kennedy, Alan R. ;

Shankland, Norman .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (09) :1918-1930

[10] Systematic investigation of the relationships between 25 crystal structures containing the carbamazepine molecule or a close analogue: a case study of the XPac method [J].

Gelbrich, T ;

Hursthouse, MB .

CRYSTENGCOMM, 2006, 8 (06) :448-460

← 1 2 3 →